Related references
Note: Only part of the references are listed.Birch-induced allergic rhinitis: Results of exposure during nasal allergen challenge, environmental chamber, and pollen season
Alina Gherasim et al.
WORLD ALLERGY ORGANIZATION JOURNAL (2023)
Allergen challenge tests in allergen im- munotherapy: State of the art
P. Zieglmayer et al.
ALLERGOLOGIE (2023)
One hundred and ten years of Allergen Immunotherapy: A journey from empiric observation to evidence
Oliver Pfaar et al.
ALLERGY (2022)
Subcutaneous birch pollen allergen immunotherapy with a depigmented polymerized extract shows only sustained and long-term efficacy in a subgroup of monosensitized adults and adolescents with allergic rhinitis
Natalija Novak et al.
CLINICAL AND TRANSLATIONAL ALLERGY (2022)
111 years of allergen-immunotherapy: A long and successful history of the only available disease-modifier in allergic diseases
J. Gutermuth et al.
ALLERGOLOGIE (2022)
Guideline for allergen immunotherapy in IgE-mediated allergic diseases
O. Pfaar et al.
ALLERGOLOGIE (2022)
Personalized medicine for allergy treatment: Allergen immunotherapy still a unique and unmatched model
Cristoforo Incorvaia et al.
ALLERGY (2021)
The use of nasal allergen vs allergen exposure chambers to evaluate allergen immunotherapy
Lubnaa Hossenbaccus et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2021)
Technical standards in allergen exposure chambers worldwide – an EAACI Task Force Report
O Pfaar et al.
ALLERGY (2021)
Algorithms in allergen immunotherapy in allergic rhinoconjunctivitis
Oliver Pfaar et al.
ALLERGY (2020)
Real-world benefits of allergen immunotherapy for birch pollen-associated allergic rhinitis and asthma
Ulrich Wahn et al.
ALLERGY (2019)
Strong dose response after immunotherapy with PQ grass using conjunctival provocation testing
S. Zielen et al.
WORLD ALLERGY ORGANIZATION JOURNAL (2019)
Efficacy and safety of birch pollen allergoid subcutaneous immunotherapy: A 2-year double-blind, placebo-controlled, randomized trial plus 1-year open-label extension
Margitta Worm et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2019)
Clinical trials in allergen immunotherapy: current concepts and future needs
O. Pfaar et al.
ALLERGY (2018)
Reliability of a New Symptom Score in a Titrated Quantitative Conjunctival Provocation Test Supported by an Objective Photodocumentation
Oliver Pfaar et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2018)
Nasal challenges in allergen immunotherapy trials
Mark W. Tenn et al.
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2018)
EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitis
G. Roberts et al.
ALLERGY (2018)
Allergoids for Allergy Treatment
Jeronimo Carnes et al.
RECENT PATENTS ON INFLAMMATION & ALLERGY DRUG DISCOVERY (2018)
Conjunctival allergen provocation test : guidelines for daily practice
J. -L. Fauquert et al.
ALLERGY (2017)
Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines-2016 revision
Jan L. Brozek et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
Dose-response relationship of a new Timothy grass pollen allergoid in comparison with a 6-grass pollen allergoid
O. Pfaar et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2017)
Efficacy and safety of sublingual tablets of house dust mite allergen extracts: Results of a dose-ranging study in an environmental exposure chamber
Michel Roux et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
Clinically relevant outcome measures for new pharmacotherapy, allergen avoidance and immunotherapy trials in allergic rhinoconjunctivitis
Oliver Pfaar et al.
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2015)
Onset and dose-related efficacy of house dust mite sublingual immunotherapy tablets in an environmental exposure chamber
Hendrik Nolte et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position Paper
O. Pfaar et al.
ALLERGY (2014)
Double-blind, placebo-controlled, dose-ranging study of new recombinant hypoallergenic Bet v 1 in an environmental exposure chamber
W. Meyer et al.
ALLERGY (2013)
Depigmented-polymerized mixed grass/birch pollen extract immunotherapy is effective in polysensitized patients
O. Pfaar et al.
ALLERGY (2013)
Depigmented Allergoids Reveal New Epitopes with Capacity to Induce IgG Blocking Antibodies
M. Angeles Lopez-Matas et al.
BIOMED RESEARCH INTERNATIONAL (2013)
Burden of allergic rhinitis: Allergies in America, Latin America, and Asia-Pacific adult surveys
Eli O. Meltzer et al.
ALLERGY AND ASTHMA PROCEEDINGS (2012)
CLINICAL AND IMMUNOLOGICAL CORRELATES OF PRE-CO-SEASONAL SUBLINGUAL IMMUNOTHERAPY WITH BIRCH MONOMERIC ALLERGOID IN PATIENTS WITH ALLERGIC RHINOCONJUNCTIVITIS
S. E. Burastero et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2009)
Prevalence and rate of diagnosis of allergic rhinitis in Europe
V Bauchau et al.
EUROPEAN RESPIRATORY JOURNAL (2004)
Share Paper
